{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["9"],"submitter":["Chen YH"],"pubmed_abstract":["Objectives
The Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) has been widely utilized to evaluate disease activity in patients with ankylosing spondylitis (AS) by an arbitrary cut-off of ≥4 to indicate high disease activity and initiate biological therapy. The Ankylosing Spondylitis Disease Activity Score (ASDAS) is a new composite index to assess AS disease activity states that have been defined and validated. ASDAS ≥2.1 was selected as a criterion to start biological therapy. The purpose of this study was to estimate the corresponding BASDAI and ASDAS cut-off in a Taiwanese AS cohort.Methods
From November 2016 to October 2018, we assessed the ASDAS and the BASDAI regularly and recorded demographic data for 489 AS patients in Taichung Veterans General hospita"],"journal":["Frontiers in medicine"],"pagination":["856654"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9149077"],"repository":["biostudies-literature"],"pubmed_title":["The BASDAI Cut-Off for Disease Activity Corresponding to the ASDAS Scores in a Taiwanese Cohort of Ankylosing Spondylitis."],"pmcid":["PMC9149077"],"pubmed_authors":["Liao YW","Hsieh TY","Chen HH","Lin CT","Tang KT","Hung WT","Wu YD","Tseng CW","Huang CY","Chen YJ","Chen YH","Lai KL","Huang WN","Chen YM","Chou YY","Hsieh CW"],"additional_accession":[]},"is_claimable":false,"name":"The BASDAI Cut-Off for Disease Activity Corresponding to the ASDAS Scores in a Taiwanese Cohort of Ankylosing Spondylitis.","description":"Objectives
The Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) has been widely utilized to evaluate disease activity in patients with ankylosing spondylitis (AS) by an arbitrary cut-off of ≥4 to indicate high disease activity and initiate biological therapy. The Ankylosing Spondylitis Disease Activity Score (ASDAS) is a new composite index to assess AS disease activity states that have been defined and validated. ASDAS ≥2.1 was selected as a criterion to start biological therapy. The purpose of this study was to estimate the corresponding BASDAI and ASDAS cut-off in a Taiwanese AS cohort.Methods
From November 2016 to October 2018, we assessed the ASDAS and the BASDAI regularly and recorded demographic data for 489 AS patients in Taichung Veterans General hospita","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022","modification":"2025-04-26T07:31:04.199Z","creation":"2025-04-06T12:17:13.536Z"},"accession":"S-EPMC9149077","cross_references":{"pubmed":["35652077"],"doi":["10.3389/fmed.2022.856654"]}}